Treatment of generalized convulsive status epilepticus: An international survey in the East Mediterranean Countries

Affiliations


Abstract

Purpose: Three Chapters of the Commission of the East Mediterranean Affairs (CEMA) of the ILAE conducted a survey to assess the availability of drugs used for the treatment of generalized convulsive status epilepticus (GCSE) across the CEMA countries and to evaluate the treatment choices of adult and pediatric neurologists for the treatment of this condition.

Method: The web-based survey consisted of two similar vignettes of GCSE in a child and an adult. The questions evaluated the sequential drugs of choice based on drug availability and with the assumption that all drugs were at the disposition of the neurologists. The neurologists were also asked about the timing of introduction of anesthetic drugs and how they monitor patients in drug induced coma.

Results: Our data showed that the availability of drugs differ substantially across CEMA countries. A benzodiazepine and phenytoin/phenobarbital were the initial drugs of choice for the majority of adults and pediatric neurologists. In cases of refractory status, most neurologists would use a third agent before proceeding to treatment with an anesthetic agent. Although the vast majority would prefer to monitor patients in drug-induced coma with continuous EEG, only 38% are using this modality because of its unavailability at their institutions.

Conclusions: Our data emphasize that an algorithm for the treatment of GCSE in the CEMA countries should be flexible and should propose different treatment options at each step of the protocol that are based on the best available data while taking into consideration the drug availability across the CEMA countries.

Keywords: Generalized convulsive status epilepticus; ILAE; survey; treatment.


Similar articles

Refractory generalised convulsive status epilepticus : a guide to treatment.

Kälviäinen R, Eriksson K, Parviainen I.CNS Drugs. 2005;19(9):759-68. doi: 10.2165/00023210-200519090-00003.PMID: 16142991 Review.

Not all patients with convulsive status epilepticus intubated in pre-hospital settings meet the criteria for refractory status epilepticus.

Zeidan S, Rohaut B, Outin H, Bolgert F, Houot M, Demoule A, Chemouni F, Combes A, Navarro V, Demeret S.Seizure. 2021 May;88:29-35. doi: 10.1016/j.seizure.2021.03.015. Epub 2021 Mar 17.PMID: 33799137

Generalized convulsive status epilepticus.

Cascino GD.Mayo Clin Proc. 1996 Aug;71(8):787-92. doi: 10.1016/S0025-6196(11)64844-1.PMID: 8691900

Variation in Anticonvulsant Selection and Electroencephalographic Monitoring Following Severe Traumatic Brain Injury in Children-Understanding Resource Availability in Sites Participating in a Comparative Effectiveness Study.

Kurz JE, Poloyac SM, Abend NS, Fabio A, Bell MJ, Wainwright MS; Investigators for the Approaches and Decisions in Acute Pediatric TBI Trial.Pediatr Crit Care Med. 2016 Jul;17(7):649-57. doi: 10.1097/PCC.0000000000000765.PMID: 27243415 Free PMC article.

The Unease When Using Anesthetics for Treatment-Refractory Status Epilepticus: Still Far Too Many Questions.

Opić P, Sutter R.J Clin Neurophysiol. 2020 Sep;37(5):399-405. doi: 10.1097/WNP.0000000000000606.PMID: 32890061 Review.


Cited by

Potential risk of liver injury in epileptic patients during COVID-19 pandemic.

Tabrizi N, Sharifi-Razavi A.World J Virol. 2022 Nov 25;11(6):467-476. doi: 10.5501/wjv.v11.i6.467.PMID: 36483103 Free PMC article. Review.


KMEL References